Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· April 22, 2026
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER
View original at finance.yahoo.comAMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER Organizational Changes Further Emphasize Integration of Biology and Technology THOUSAND OAKS, Calif., April 22, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the retirement of David M…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The capabilities he built position us to advance what we call convergent innovation and strengthen our ability to serve patients in the years ahead
60% confidenceDave recognized early the impact that advances in biology and technology would have on our industry and helped lead Amgen through that shift
60% confidenceReese encouraged the early adoption of technology and artificial intelligence across all facets of the business, in particular R&D
60% confidenceReese led approvals of numerous innovative medicines and biosimilars, advanced a robust pipeline of potential new therapies and strengthened discovery research capabilities during his tenure
60% confidence
Cited in these Via News reports
- $2.52 Trillion AI Spending Forecast Reshapes Corporate Capital Allocation →
- 88% of Executives Regret Rushing Into Agentic AI Before Governance Was Ready →
- ADC Combination Trials Converge on 2026-2027 Regulatory Window, Concentrating Biotech Binary Risk →
- AI Agents Replace Co-Pilots as Enterprise Operating Models Face Mandatory Redesign →
- Amgen Leads Fortune 500 AI Restructuring as Enterprise Infrastructure Moves Past Pilot Phase →
- Amgen Merges R&D and AI Under Single Leader as Generative Oncology Race Heats Up →
- Dell, NVIDIA, Google Race to Own the Enterprise AI Platform Layer Before Late-2026 Agentic Wave →
- Dell, NVIDIA, Oracle Fight to Own Enterprise AI Stack as Domain Expertise Displaces Model Access →
- Dell, SAP, Oracle Race to Own Enterprise AI Control Layer as Model Commoditization Accelerates →
- Enterprise AI Crosses Into Agentic Operations as Vendors Race to Replace Human-Centric Workflows →
- Enterprise AI Moves Beyond Pilots as Incumbents Build Domain Data Moats →
- Enterprises Shift AI Strategy From Copilots to Autonomous Agents, Forcing Operating Model Overhauls →
- FDA PDUFA Wave in 2026 Sets Up Binary Catalyst Season Across ADC, Cell Therapy, and Checkpoint Inhibitor Portfolios →
- Fanatics and Thomson Reuters Deploy Snowflake's AI Agent Platform as Enterprise Automation Moves to Production →
- H2 2026 FDA Decision Cluster Forces Biotech Repricing Across ADCs and Cell Therapies →
- Vepdegestrant's 5-Month PFS Anchors Rigel-Arvinas-Pfizer Deal as Three PDUFA Dates Cluster in 2026 →
